نمایش پرونده ساده آیتم

dc.contributor.advisorAla, Alireza
dc.contributor.advisorGhilani, Neda
dc.contributor.authorKouhestani, Elham
dc.date.accessioned2022-04-27T05:34:36Z
dc.date.available2022-04-27T05:34:36Z
dc.date.issued2021en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/66527
dc.description.abstractThe etiology of hemorrhagic stroke, although generally defined in the world, but due to the variety of antithrombotic drugs used and arbitrary use of antithrombotic drugs, this etiology seems to be completely different. Therefore, the aim is to investigate the type of common etiology, which if the cause of the drug is common, the type of drug is also possible. Methods: In this study, which is an observational cross-sectional study, patients who referred to the emergency department of Imam Reza Hospital during 1398 and 1397 with a complaint of hemorrhagic stroke and did not meet the exclusion criteria, were included in the study. Were. The studied variables are patient demographics, comorbidities, risk factors, patient anticoagulants, treatment performed and patient outcome. Results: In this study, in which 323 people were included, the mean age of patients was 64.80 ± 14.30 years and the mean age of the population was between 58 and 75 years. Of these patients, 148 patients (45.8%) in 1397 and 175 patients (54.2%) in 1398 have referred to the emergency department, which can be seen that this number of patients shows almost the same annual incidence. Patients weighed 70 kg with an average weight of 65 to 79 kg. The most common findings in these patients are decreased level of consciousness, headache, vomiting, and visual disturbances such as sudden blindness, visual field disturbance, and diplopia. In the study of patients' clinical course, 78.9% of patients had a stable condition and 15.5% had a worsening process, but a small percentage of patients had a improvement in symptoms. In examining the risk factors of patients with hemorrhagic stroke, the main risk factor is blood pressure. Among them, only 17 patients, including 5.3% of patients, were taking anticoagulants, and 64 patients, who accounted for nearly 20% of patients, were taking antithrombotic drugs.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/66526en_US
dc.subjectStrokeen_US
dc.subjectHemorrhagic Strokeen_US
dc.subjectAnticoagulanten_US
dc.titleDrug Etiology of hemorrhagic stroke in patients with acute strokeen_US
dc.typeThesisen_US
dc.contributor.supervisorShams Vahdati, Samad
dc.contributor.supervisorSadeghi-Hokmabadi, Elyar
dc.identifier.docno6010334en_US
dc.identifier.callno10334en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم